PharmaTher Holdings Ltd. (OTCMKTS:PHRRF – Get Free Report) passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.04 and traded as high as $0.0403. PharmaTher shares last traded at $0.0403, with a volume of 214,990 shares traded.
PharmaTher Trading Up 6.3%
The business has a 50-day moving average price of $0.04 and a 200-day moving average price of $0.05.
PharmaTher Company Profile
PharmaTher Inc is a specialty pharmaceutical company focused on the development and commercialization of repurposed and reformulated medicines for neurological and psychiatric conditions. The company’s strategy centers on advancing existing drug compounds through new formulations, delivery methods, or therapeutic applications.
PharmaTher has historically focused on ketamine-based treatments, including programs intended to address conditions such as depression and other mental-health disorders.
Featured Stories
- Five stocks we like better than PharmaTher
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for PharmaTher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaTher and related companies with MarketBeat.com's FREE daily email newsletter.
